X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Indoco Remedies with TIMKEN INDIA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs TIMKEN INDIA - Comparison Results

INDOCO REMEDIES    Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

TIMKEN INDIA 
   Change

Tata Timken Ltd. (TTL), the country`s second largest ball-bearing (tapered and cartridge tapered) manufacturer after SKF, has become an 80% subsidiary of the $2.4 billion family controlled Timken USA, after buying out the Tata`s 40% stake in the comp... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES TIMKEN INDIA INDOCO REMEDIES/
TIMKEN INDIA
 
P/E (TTM) x 22.9 49.3 46.5% View Chart
P/BV x 2.7 7.8 35.1% View Chart
Dividend Yield % 0.8 0.1 585.6%  

Financials

 INDOCO REMEDIES   TIMKEN INDIA
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-17
TIMKEN INDIA
Mar-17
INDOCO REMEDIES/
TIMKEN INDIA
5-Yr Chart
Click to enlarge
High Rs360675 53.4%   
Low Rs249435 57.3%   
Sales per share (Unadj.) Rs119.0155.3 76.6%  
Earnings per share (Unadj.) Rs8.414.3 58.5%  
Cash flow per share (Unadj.) Rs15.218.5 82.1%  
Dividends per share (Unadj.) Rs1.601.00 160.0%  
Dividend yield (eoy) %0.50.2 291.4%  
Book value per share (Unadj.) Rs70.790.9 77.8%  
Shares outstanding (eoy) m92.1568.00 135.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.63.6 71.7%   
Avg P/E ratio x36.438.8 93.8%  
P/CF ratio (eoy) x20.029.9 66.8%  
Price / Book Value ratio x4.36.1 70.6%  
Dividend payout %19.17.0 273.5%   
Avg Mkt Cap Rs m28,08337,743 74.4%   
No. of employees `0006.00.7 841.8%   
Total wages/salary Rs m2,167737 293.9%   
Avg. sales/employee Rs Th1,817.014,730.5 12.3%   
Avg. wages/employee Rs Th359.01,028.2 34.9%   
Avg. net profit/employee Rs Th127.71,355.6 9.4%   
INCOME DATA
Net Sales Rs m10,96810,562 103.8%  
Other income Rs m4099 40.0%   
Total revenues Rs m11,00710,661 103.2%   
Gross profit Rs m1,5651,580 99.0%  
Depreciation Rs m633289 219.0%   
Interest Rs m628 739.3%   
Profit before tax Rs m9091,382 65.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m139410 33.8%   
Profit after tax Rs m771972 79.3%  
Gross profit margin %14.315.0 95.4%  
Effective tax rate %15.329.7 51.4%   
Net profit margin %7.09.2 76.4%  
BALANCE SHEET DATA
Current assets Rs m5,7255,494 104.2%   
Current liabilities Rs m5,4542,331 234.0%   
Net working cap to sales %2.529.9 8.2%  
Current ratio x1.02.4 44.5%  
Inventory Days Days6265 95.7%  
Debtors Days Days7266 108.1%  
Net fixed assets Rs m5,3072,887 183.8%   
Share capital Rs m184680 27.1%   
"Free" reserves Rs m6,3315,499 115.1%   
Net worth Rs m6,5166,179 105.5%   
Long term debt Rs m1,3230-   
Total assets Rs m11,9708,727 137.2%  
Interest coverage x15.6165.5 9.5%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.91.2 75.7%   
Return on assets %7.011.2 61.9%  
Return on equity %11.815.7 75.2%  
Return on capital %12.422.5 55.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,5073,293 136.9%   
Fx outflow Rs m1,1412,491 45.8%   
Net fx Rs m3,366802 419.6%   
CASH FLOW
From Operations Rs m8861,642 54.0%  
From Investments Rs m-1,706-1,251 136.3%  
From Financial Activity Rs m1,316-47 -2,793.4%  
Net Cashflow Rs m497344 144.4%  

Share Holding

Indian Promoters % 59.2 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 12.5 5.5 227.3%  
FIIs % 6.0 6.4 93.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 13.2 169.7%  
Shareholders   12,805 49,890 25.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   GEOJIT BNP PARIBAS  KOTHARI PRODUCTS  NESCO LIMITED  IIFL HOLDINGS  GREENPLY IND  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Aug 16, 2017 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 5-YR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS